J&J touts their head-to-head win against Sanofi on MS, steer­ing an­oth­er S1P drug to the FDA

J&J in­ves­ti­ga­tors say they racked up a pos­i­tive set of num­bers for their Phase III piv­otal study of the S1P1 drug pones­i­mod in a head …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.